Aptose Biosciences Stock Price History
APTO Stock | USD 1.27 0.01 0.79% |
Below is the normalized historical share price chart for Aptose Biosciences extending back to March 16, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aptose Biosciences stands at 1.27, as last reported on the 19th of April, with the highest price reaching 1.29 and the lowest price hitting 1.25 during the day.
If you're considering investing in Aptose Stock, it is important to understand the factors that can impact its price. Aptose Biosciences secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15% return per unit of risk over the last 3 months. Aptose Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aptose Biosciences' Standard Deviation of 4.16, risk adjusted performance of (0.11), and Mean Deviation of 3.06 to double-check the risk estimate we provide.
At this time, Aptose Biosciences' Common Stock Total Equity is very stable compared to the past year. As of the 19th of April 2024, Stock Based Compensation is likely to grow to about 4 M, though Total Stockholder Equity is likely to grow to (2.7 M). . As of the 19th of April 2024, Price To Sales Ratio is likely to drop to about 12.4 K. In addition to that, Price Earnings Ratio is likely to drop to -0.35. Aptose Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of October 2014 | 200 Day MA 2.7249 | 50 Day MA 1.6642 | Beta 1.424 |
Aptose |
Sharpe Ratio = -0.1506
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | APTO |
Estimated Market Risk
4.13 actual daily | 36 64% of assets are more volatile |
Expected Return
-0.62 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aptose Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aptose Biosciences by adding Aptose Biosciences to a well-diversified portfolio.
Price Book 3.353 | Book Value (0.36) | Enterprise Value 11.6 M | Enterprise Value Ebitda (0.26) | Shares Float 12.5 M |
Aptose Biosciences Stock Price History Chart
There are several ways to analyze Aptose Stock price data. The simplest method is using a basic Aptose candlestick price chart, which shows Aptose Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | February 6, 2024 | 2.18 |
Lowest Price | April 17, 2024 | 1.26 |
Aptose Biosciences April 19, 2024 Stock Price Synopsis
Various analyses of Aptose Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aptose Stock. It can be used to describe the percentage change in the price of Aptose Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aptose Stock.Aptose Biosciences Price Action Indicator | 0.01 | |
Aptose Biosciences Accumulation Distribution | 1,060 | |
Aptose Biosciences Price Rate Of Daily Change | 1.01 | |
Aptose Biosciences Price Daily Balance Of Power | 0.25 |
Aptose Biosciences April 19, 2024 Stock Price Analysis
Aptose Stock Price History Data
The price series of Aptose Biosciences for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 has a statistical range of 0.97 with a coefficient of variation of 15.96. The prices are distributed with arithmetic mean of 1.74. The median price for the last 90 days is 1.8. The company had 1:12 stock split on 6th of October 2014.Open | High | Low | Close | Volume | ||
04/18/2024 | 1.25 | 1.29 | 1.25 | 1.27 | 34,175 | |
04/17/2024 | 1.27 | 1.34 | 1.26 | 1.26 | 31,324 | |
04/16/2024 | 1.29 | 1.32 | 1.20 | 1.27 | 45,647 | |
04/15/2024 | 1.39 | 1.40 | 1.29 | 1.30 | 65,087 | |
04/12/2024 | 1.39 | 1.44 | 1.34 | 1.36 | 35,185 | |
04/11/2024 | 1.40 | 1.43 | 1.37 | 1.38 | 51,284 | |
04/10/2024 | 1.39 | 1.48 | 1.38 | 1.38 | 54,000 | |
04/09/2024 | 1.48 | 1.49 | 1.40 | 1.41 | 179,377 | |
04/08/2024 | 1.45 | 1.52 | 1.38 | 1.47 | 113,186 | |
04/05/2024 | 1.41 | 1.47 | 1.38 | 1.38 | 56,085 | |
04/04/2024 | 1.47 | 1.56 | 1.39 | 1.43 | 134,593 | |
04/03/2024 | 1.57 | 1.58 | 1.44 | 1.44 | 113,290 | |
04/02/2024 | 1.65 | 1.67 | 1.51 | 1.58 | 102,657 | |
04/01/2024 | 1.72 | 1.72 | 1.53 | 1.60 | 122,551 | |
03/28/2024 | 1.50 | 1.70 | 1.50 | 1.66 | 137,093 | |
03/27/2024 | 1.50 | 1.54 | 1.46 | 1.50 | 78,979 | |
03/26/2024 | 1.54 | 1.60 | 1.48 | 1.60 | 57,461 | |
03/25/2024 | 1.61 | 1.61 | 1.49 | 1.51 | 53,491 | |
03/22/2024 | 1.58 | 1.62 | 1.50 | 1.55 | 91,097 | |
03/21/2024 | 1.51 | 1.59 | 1.47 | 1.57 | 42,116 | |
03/20/2024 | 1.48 | 1.52 | 1.46 | 1.52 | 17,562 | |
03/19/2024 | 1.48 | 1.59 | 1.40 | 1.50 | 148,862 | |
03/18/2024 | 1.52 | 1.54 | 1.47 | 1.50 | 43,570 | |
03/15/2024 | 1.40 | 1.52 | 1.37 | 1.52 | 71,185 | |
03/14/2024 | 1.47 | 1.47 | 1.36 | 1.40 | 59,487 | |
03/13/2024 | 1.57 | 1.57 | 1.42 | 1.44 | 73,376 | |
03/12/2024 | 1.60 | 1.60 | 1.48 | 1.50 | 56,155 | |
03/11/2024 | 1.69 | 1.69 | 1.53 | 1.58 | 77,999 | |
03/08/2024 | 1.74 | 1.74 | 1.56 | 1.63 | 111,828 | |
03/07/2024 | 1.69 | 1.71 | 1.65 | 1.68 | 30,169 | |
03/06/2024 | 1.81 | 1.82 | 1.60 | 1.67 | 106,653 | |
03/05/2024 | 1.83 | 1.83 | 1.72 | 1.76 | 115,727 | |
03/04/2024 | 1.83 | 1.87 | 1.75 | 1.81 | 102,999 | |
03/01/2024 | 1.82 | 1.87 | 1.75 | 1.87 | 53,965 | |
02/29/2024 | 1.90 | 1.90 | 1.74 | 1.80 | 112,441 | |
02/28/2024 | 1.90 | 1.94 | 1.76 | 1.85 | 85,440 | |
02/27/2024 | 1.92 | 1.94 | 1.85 | 1.90 | 91,611 | |
02/26/2024 | 1.80 | 1.93 | 1.80 | 1.90 | 86,958 | |
02/23/2024 | 1.81 | 1.86 | 1.78 | 1.86 | 61,672 | |
02/22/2024 | 1.81 | 1.89 | 1.77 | 1.78 | 113,856 | |
02/21/2024 | 1.93 | 1.98 | 1.84 | 1.84 | 55,385 | |
02/20/2024 | 2.01 | 2.01 | 1.87 | 1.95 | 89,510 | |
02/16/2024 | 2.02 | 2.04 | 1.88 | 1.95 | 86,795 | |
02/15/2024 | 1.95 | 2.08 | 1.95 | 2.02 | 64,372 | |
02/14/2024 | 2.02 | 2.02 | 1.85 | 1.95 | 130,568 | |
02/13/2024 | 2.06 | 2.12 | 1.94 | 1.95 | 118,542 | |
02/12/2024 | 2.02 | 2.16 | 2.02 | 2.06 | 63,390 | |
02/09/2024 | 2.05 | 2.10 | 1.98 | 2.03 | 100,814 | |
02/08/2024 | 2.10 | 2.13 | 2.01 | 2.07 | 47,298 | |
02/07/2024 | 2.20 | 2.20 | 2.05 | 2.09 | 91,293 | |
02/06/2024 | 2.07 | 2.20 | 2.05 | 2.18 | 106,845 | |
02/05/2024 | 2.06 | 2.08 | 1.94 | 2.02 | 152,047 | |
02/02/2024 | 2.00 | 2.00 | 1.92 | 2.00 | 47,634 | |
02/01/2024 | 2.09 | 2.09 | 1.94 | 1.98 | 92,867 | |
01/31/2024 | 1.97 | 2.01 | 1.94 | 2.00 | 71,857 | |
01/30/2024 | 1.97 | 2.00 | 1.89 | 1.99 | 94,717 | |
01/29/2024 | 2.08 | 2.08 | 1.81 | 1.96 | 89,600 | |
01/26/2024 | 1.80 | 2.11 | 1.69 | 1.98 | 816,360 | |
01/25/2024 | 2.10 | 2.15 | 1.87 | 1.90 | 127,828 | |
01/24/2024 | 2.01 | 2.14 | 1.92 | 2.09 | 82,825 | |
01/23/2024 | 1.99 | 2.01 | 1.88 | 1.89 | 98,196 |
About Aptose Biosciences Stock history
Aptose Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aptose is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aptose Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aptose Biosciences stock prices may prove useful in developing a viable investing in Aptose Biosciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 6.8 M | 6.4 M | |
Net Loss | -37.6 M | -35.8 M |
Aptose Biosciences Stock Technical Analysis
Aptose Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
All Next | Launch Module |
Aptose Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aptose Biosciences' price direction in advance. Along with the technical and fundamental analysis of Aptose Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aptose to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.11) | |||
Jensen Alpha | (0.80) | |||
Total Risk Alpha | (1.17) | |||
Treynor Ratio | (2.08) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Aptose Stock analysis
When running Aptose Biosciences' price analysis, check to measure Aptose Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptose Biosciences is operating at the current time. Most of Aptose Biosciences' value examination focuses on studying past and present price action to predict the probability of Aptose Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptose Biosciences' price. Additionally, you may evaluate how the addition of Aptose Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Aptose Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptose Biosciences. If investors know Aptose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptose Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.58) | Return On Assets (1.02) | Return On Equity (2.94) |
The market value of Aptose Biosciences is measured differently than its book value, which is the value of Aptose that is recorded on the company's balance sheet. Investors also form their own opinion of Aptose Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aptose Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptose Biosciences' market value can be influenced by many factors that don't directly affect Aptose Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.